ValiRx plc (AIM:VAL)
London
· Delayed Price · Currency is GBP · Price in GBX 0.270
-0.010 (-3.57%)
Apr 29, 2026, 10:28 AM GMT
ValiRx Revenue
ValiRx had revenue of 49.78K GBP in the twelve months ending June 30, 2025, up 418.49% year-over-year. In the year 2024, ValiRx had annual revenue of 49.78K with 418.49% growth.
Revenue
49.78K
Revenue Growth
+418.49%
P/S Ratio
41.78
Revenue / Employee
3.56K
Employees
14
Market Cap
2.08M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Physiomics | 1.01M |
| BSF Enterprise | 52.84K |
| Thalia Therapeutics | 7.07K |
| OptiBiotix Health | 1.15M |
| CRISM Therapeutics | 25.00K |
| Futura Medical | 7.93M |
| Oxford BioDynamics | 1.10M |
ValiRx News
- 6 months ago - AIM Market Roundup: Haydale Graphene, Marechale Capital, Getech - The Armchair Trader
- 1 year ago - Small Cap Stocks: Catenai, Genip, ValiRx - The Armchair Trader
- 1 year ago - Small Cap Stocks: Guardian Metal, MediaZest, Enwell - The Armchair Trader
- 1 year ago - Small Cap Stocks: Valirx, EnergyPathways, Merit Group - The Armchair Trader